Design, synthesis and biological evaluation of 5-amino-4-(1H-benzoimidazol-2-yl)-phenyl-1,2-dihydro-pyrrol-3-ones as inhibitors of protein kinase FGFR1

Monday, 28 March 2016

Our paper dedicated to the development of novel inhibitors of protein kinase FGFR1 has been published in Bioorganic and Medicinal Chemistry.

Abstract:

Fibroblast growth...

Contract Research with OTAVA Research and Development Company

Tuesday, 16 February 2016

Institute of Molecular Biology and Genetics, the NAS of Ukraine has concluded Agreement concerning commercialization of scientific results with OTAVA Research and Development Company Ltd...

Appeal to Publishers concerning affiliation “Crimea, Russia”

Wednesday, 16 December 2015

Scientific Researchers of the Department of Medicinal Chemistry of the Institute of Molecular Biology and Genetics, the NAS of Ukraine, support the appeal to publishers which publish...

Contract Research with Novartis

Tuesday, 03 November 2015

The Department of Medicinal Chemistry of the Institute of Molecular Biology and Genetics of the NAS of Ukraine has played a leading role in signing of Master Services Agreement with...

News and Events

Design, synthesis and biological evaluation of 5-amino-4-(1H-benzoimidazol-2-yl)-phenyl-1,2-dihydro-pyrrol-3-ones as inhibitors of protein kinase FGFR1

Contract Research with OTAVA Research and Development Company

Appeal to Publishers concerning affiliation “Crimea, Russia”

Contract Research with Novartis

Our research:

FGFR1 Inhibitors

CK2 Inhibitors

ASK1 Inhibitors

Fluorescent Probes

Molecular Design